Will Spooren

11.7k total citations · 1 hit paper
95 papers, 7.1k citations indexed

About

Will Spooren is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Will Spooren has authored 95 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Cellular and Molecular Neuroscience, 37 papers in Molecular Biology and 26 papers in Cognitive Neuroscience. Recurrent topics in Will Spooren's work include Neuroscience and Neuropharmacology Research (42 papers), Receptor Mechanisms and Signaling (22 papers) and Autism Spectrum Disorder Research (18 papers). Will Spooren is often cited by papers focused on Neuroscience and Neuropharmacology Research (42 papers), Receptor Mechanisms and Signaling (22 papers) and Autism Spectrum Disorder Research (18 papers). Will Spooren collaborates with scholars based in Switzerland, Netherlands and United States. Will Spooren's co-authors include F. Gasparini, Laurence Ozmen, Pico Caroni, Declan Murphy, C. Gentsch, Theresa M. Ballard, Jacques Borg, Lan Xu, Corinna Schneider and Georg Jaeschke and has published in prestigious journals such as Science, Journal of Clinical Investigation and Neuron.

In The Last Decade

Will Spooren

94 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early and Selective Loss of Neuromuscular Synapse Subtypes with Low Sprouting Competence in Motoneuron Diseases

2000 541 citations Will Spooren et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Will Spooren Switzerland	41	3.8k	2.7k	2.2k	1.8k	1.2k	95	7.1k
Don M. Gash United States	54	6.4k 1.7×	2.2k 0.8×	3.3k 1.5×	2.0k 1.1×	450 0.4×	199	10.2k
Gorazd Rosoklija United States	36	2.1k 0.5×	1.9k 0.7×	885 0.4×	1.2k 0.7×	791 0.7×	82	6.9k
Allan J. Tobin United States	45	5.4k 1.4×	3.5k 1.3×	1.3k 0.6×	767 0.4×	2.1k 1.7×	105	9.9k
Alessandro Usiello Italy	49	3.8k 1.0×	3.2k 1.2×	1.2k 0.6×	783 0.4×	407 0.3×	145	7.3k
Wing‐Ho Yung Hong Kong	47	3.1k 0.8×	2.0k 0.7×	965 0.4×	1.0k 0.6×	335 0.3×	180	7.3k
Péter Klivènyi Hungary	40	2.3k 0.6×	3.1k 1.2×	1.9k 0.9×	678 0.4×	281 0.2×	214	7.2k
Brandon K. Harvey United States	49	3.2k 0.8×	2.7k 1.0×	760 0.3×	1.0k 0.6×	364 0.3×	119	7.2k
F H Gage United States	26	4.0k 1.0×	2.0k 0.7×	531 0.2×	1.5k 0.8×	490 0.4×	36	6.8k
David J. A. Wyllie United Kingdom	46	4.5k 1.2×	4.3k 1.6×	470 0.2×	1.3k 0.7×	623 0.5×	100	6.9k

Countries citing papers authored by Will Spooren

Since Specialization

Citations

This map shows the geographic impact of Will Spooren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Will Spooren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Will Spooren more than expected).

Fields of papers citing papers by Will Spooren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Will Spooren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Will Spooren. The network helps show where Will Spooren may publish in the future.

Co-authorship network of co-authors of Will Spooren

This figure shows the co-authorship network connecting the top 25 collaborators of Will Spooren. A scholar is included among the top collaborators of Will Spooren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Will Spooren. Will Spooren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horder, Jamie, Marija M. Petrinovic, María Andreina Méndez, et al.. (2018). Glutamate and GABA in autism spectrum disorder—a translational magnetic resonance spectroscopy study in man and rodent models. Translational Psychiatry. 8(1). 106–106. 206 indexed citations

Kabitzke, Patricia, Daniela Brunner, Kimberly H. Cox, et al.. (2017). Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder. Genes Brain & Behavior. 17(1). 4–22. 42 indexed citations

Berry‐Kravis, Elizabeth, Lothar Lindemann, Aia Elise Jønch, et al.. (2017). Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nature Reviews Drug Discovery. 17(4). 280–299. 233 indexed citations

Malherbe, Pari, Frédéric Knoflach, Anne Marcuz, et al.. (2014). Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK3 receptor antagonist: Biochemical and electrophysiological characterization. Neuropharmacology. 86. 259–272. 4 indexed citations

Murphy, Declan, Michel Goldman, Eva Loth, & Will Spooren. (2014). Public-Private Partnership: A New Engine for Translational Research in Neurosciences. Neuron. 84(3). 533–536. 6 indexed citations

Vorstman, Jacob, Will Spooren, Antonio M. Persico, et al.. (2013). Using genetic findings in autism for the development of new pharmaceutical compounds. Psychopharmacology. 231(6). 1063–1078. 26 indexed citations

Spooren, Will, Lothar Lindemann, Anirvan Ghosh, & Luca Santarelli. (2012). Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends in Pharmacological Sciences. 33(12). 669–684. 100 indexed citations

Salomons, Amber R., Hetty Boleij, Susanne Kirchhoff, et al.. (2012). Differential effects of diazepam and MPEP on habituation and neuro-behavioural processes in inbred mice. Behavioral and Brain Functions. 8(1). 30–30. 13 indexed citations

Goeldner, Celia, Will Spooren, Jürgen Wichmann, & Eric Prinssen. (2012). Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair. Psychopharmacology. 222(2). 203–214. 25 indexed citations

10.

Lindemann, Lothar, Georg Jaeschke, Aubin Michalon, et al.. (2011). CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 339(2). 474–486. 91 indexed citations

11.

Nordquist, Rebecca E., Hélène M. Savignac, Meike Pauly-Evers, et al.. (2008). Characterization of behavioral response to amphetamine, tyrosine hydroxylase levels, and dopamine receptor levels in neurokinin 3 receptor knockout mice. Behavioural Pharmacology. 19(5-6). 518–529. 12 indexed citations

12.

Nordquist, Rebecca E., Sean Durkin, Georg Jaeschke, & Will Spooren. (2007). Stress-induced hyperthermia: Effects of acute and repeated dosing of MPEP. European Journal of Pharmacology. 568(1-3). 199–202. 18 indexed citations

13.

Ceccarelli, Simona, Georg Jaeschke, Bernd Buettelmann, et al.. (2006). Rational design, synthesis, and structure–activity relationship of benzoxazolones: New potent mglu5 receptor antagonists based on the fenobam structure. Bioorganic & Medicinal Chemistry Letters. 17(5). 1302–1306. 20 indexed citations

14.

Spooren, Will, Claus Riemer, & Herbert Y. Meltzer. (2005). NK3 receptor antagonists: the next generation of antipsychotics?. Nature Reviews Drug Discovery. 4(12). 967–975. 94 indexed citations

15.

Cryan, John F., Peter H. Kelly, Frédérique Chaperon, et al.. (2004). Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines. Journal of Pharmacology and Experimental Therapeutics. 310(3). 952–963. 173 indexed citations

16.

Neumann, Manuela, Philipp J. Kahle, Benoit I. Giasson, et al.. (2002). Misfolded proteinase K–resistant hyperphosphorylated α-synuclein in aged transgenic mice with locomotor deterioration and in human α-synucleinopathies. Journal of Clinical Investigation. 110(10). 1429–1439. 282 indexed citations

17.

Kühn, Ralf, Natacha Stoehr, Ivo Vranesic, et al.. (2002). In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: Review article. Amino Acids. 23(1-3). 207–211. 40 indexed citations

18.

Ludbrook, John, et al.. (2000). Different Outcomes of the Wilcoxon—Mann—Whitney Test from Different Statistics Packages. The American Statistician. 54(1). 72–77. 147 indexed citations

19.

Spooren, Will, et al.. (1991). Dopamine D1 receptors in the sub-commissural part of the globus pallidus and their role in oro-facial dyskinesia in cats. European Journal of Pharmacology. 204(2). 217–222. 14 indexed citations

20.

Cools, A.R., et al.. (1989). Anatomically distinct output channels of the caudate nucleus and orofacial dyskinesia: Critical role of the subcommissural part of the globus pallidus in oral dyskinesia. Neuroscience. 33(3). 535–542. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact